Recombinant Euschistus servus Tachykinin-related peptide 2

What is Recombinant Euschistus servus Tachykinin-related peptide 2?

Recombinant Euschistus servus Tachykinin-related peptide 2 (TKRP-2) is a neuropeptide originally identified in the brown stink bug (Euschistus servus). It belongs to the tachykinin-related peptide family, which differs from vertebrate tachykinins in their C-terminal amino acid composition. The commercially available recombinant protein is produced in E. coli expression systems with a purity of >85% as determined by SDS-PAGE. The peptide consists of 10 amino acids with the sequence APAAGFFGMR and corresponds to the expression region 1-10 of the native protein .

How does TKRP-2 structurally compare to other tachykinin-related peptides?

TKRP-2 belongs to the invertebrate tachykinin-related peptide (TKRP) subfamily. While vertebrate tachykinins typically share a consensus C-terminal region (F-X-G-Y-R-NH₂), TKRPs like those found in Euschistus servus have a modified C-terminal composition. Similar TKRPs have been identified in other hemipterans including Nezara viridula, Banasa dimiata, and Rhodnius prolixus. The TKRP-2 from Euschistus servus maintains structural homology with other insect TKRPs while exhibiting species-specific sequence variations, particularly in the N-terminal region .

What are the optimal storage conditions for maintaining TKRP-2 stability?

For optimal stability, TKRP-2 should be stored at -20°C for regular use, or at -80°C for extended storage periods. The peptide should be reconstituted in deionized sterile water to a concentration of 0.1-1.0 mg/mL. To prevent degradation during storage, it is recommended to add glycerol to a final concentration of 5-50% (with 50% being standard practice). Once reconstituted, working aliquots can be stored at 4°C for up to one week. Repeated freeze-thaw cycles should be avoided as they may compromise the peptide's structural integrity and biological activity .

What reconstitution protocol yields optimal TKRP-2 bioactivity for experimental applications?

For optimal reconstitution of TKRP-2:

• Centrifuge the vial briefly prior to opening to ensure all content is at the bottom

• Reconstitute the lyophilized peptide in deionized sterile water to achieve a concentration of 0.1-1.0 mg/mL

• Add glycerol to a final concentration of 5-50% (50% is recommended) for stability

• Prepare multiple small-volume aliquots to avoid repeated freeze-thaw cycles

• For working solutions, store aliquots at 4°C for up to one week

• For long-term storage, keep aliquots at -20°C/-80°C

This protocol maximizes peptide stability while maintaining bioactivity for experimental applications. The shelf life is approximately 6 months for the liquid form at -20°C/-80°C and 12 months for the lyophilized form at the same temperatures .

How can researchers assess TKRP-2 receptor binding affinity in vitro?

Researchers can assess TKRP-2 receptor binding using cell-based assays with HEK293 or Sf21 cells transfected with the TRPR (tachykinin-related peptide receptor). The experimental workflow includes:

• Cell preparation: Transfect cells with the TRPR expression construct

• cAMP accumulation assay: Measure intracellular cAMP levels following TKRP-2 treatment

• Calcium mobilization assay: Measure intracellular Ca²⁺ release

• ERK phosphorylation analysis: Use Western blotting to detect phosphorylated ERK

• Dose-response evaluation: Test multiple concentrations (ranging from 1-1000 nM) to determine EC₅₀ values

• Comparative analysis: Include other neuropeptides as negative controls (e.g., SNF, PDH, CRZ)

• Pathway verification: Use specific inhibitors (U0126, H89, Go6983) to verify signaling pathways

Research has shown that TKRP-2 displays stronger binding affinity to the TRPR receptor compared to TKRP-3, with activation triggering Gαq and Gαs pathways and subsequent ERK cascade activation .

What protocols are available for evaluating TKRP-2 stability in biological matrices?

To evaluate TKRP-2 stability in biological matrices, researchers can employ a serum stability assay:

• Prepare a peptide solution at 10 mg/mL

• Add 20 μL of this solution to 1 mL of 25% non-heat inactivated serum (e.g., horse serum) in PBS

• Incubate at physiological temperature (37°C)

• Collect samples at defined time intervals (0, 10, 30, 60, and 120 minutes)

• For each time point, withdraw 100 μL and add 10 μL of trifluoroacetic acid to stop enzymatic activity

• Incubate these samples at 5°C for 15 minutes

• Centrifuge at 300 × g for 5 minutes

• Analyze 30 μL of the supernatant using HPLC coupled to mass spectrometry

• Quantify remaining intact peptide at each time point relative to the 0-minute sample

This methodology allows for determination of the peptide's half-life in physiological conditions and identification of specific degradation products, which is crucial for understanding its pharmacokinetic properties and potential modifications to improve stability .

What signaling pathways are activated by TKRP-2 and how can they be experimentally verified?

TKRP-2 activates multiple signaling pathways through binding to the TRPR receptor. These pathways and their experimental verification methods include:

The activation of these pathways has been confirmed in both HEK293 and Sf21 cells expressing TRPR. TKRP-2 induces transient ERK phosphorylation with maximal effect at 2 minutes post-treatment, returning to near basal levels by 90 minutes. The EC₅₀ for ERK phosphorylation is approximately 68.04 nM in HEK293 cells and 1.68 nM in Sf21 cells. Importantly, pertussis toxin (PTX), a Gαi inhibitor, shows no effect on TKRP-2 signaling, confirming specificity to Gαs and Gαq pathways .

How does TKRP-2 affect behavioral responses in model organisms?

Studies in honeybees (Apis mellifera) demonstrate that TKRP-2 modulates task-specific behavioral responses in a specialized manner. The experimental evidence shows:

• Injection effects: When TKRP-2 is injected into different behavioral phenotypes of honeybees (pollen foragers, nectar foragers, and nurse bees), it reduces task-specific responsiveness.

• Sucrose response: TKRP-2 significantly reduces the sucrose response score (SRS) in both pollen foragers (PFs) and nectar foragers (NFs), decreasing their proboscis extension response (PER) to all sucrose concentrations except 0.1% in NFs.

• Pollen responsiveness: TKRP-2 significantly decreases responsiveness to pollen loads in PFs but not in NFs or nurse bees (NBs).

• Larval responsiveness: TKRP-2 significantly affects only the larval responsiveness of NBs, not PFs or NFs.

These findings indicate that TKRP-2 acts as an inhibitory modulator of task-specific behaviors, raising the response threshold in a phenotype-specific manner. This suggests that tachykinin signaling plays a crucial role in regulating the degree of behavioral specialization in social insects .

Does TKRP-2 possess antimicrobial properties similar to other insect-derived peptides?

While TKRP-2 from Euschistus servus has not been specifically tested for antimicrobial activity, related TKRP peptides from other insects in the order Hemiptera have demonstrated antimicrobial properties. For instance, TRP2-TINF isolated from Triatoma infestans exhibits antimicrobial activity primarily against Gram-negative bacteria such as Pseudomonas aeruginosa and Escherichia coli with a minimum inhibitory concentration of approximately 45 μM.

The antimicrobial activity of TKRPs appears to be related to their secondary structure. TRP2-TINF, which has a 310 helix secondary structure, is susceptible to carboxypeptidase degradation but maintains antimicrobial activity. To evaluate potential antimicrobial properties of TKRP-2 from Euschistus servus, researchers should employ:

• Microdilution assays against Gram-positive and Gram-negative bacteria

• Determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC)

• Assessment of hemolytic activity against human erythrocytes

• Cytotoxicity testing against mammalian cell lines

These studies would help determine whether TKRP-2 from Euschistus servus shares the antimicrobial properties observed in other hemipteran TKRPs .

How can synthetic variants of TKRP-2 be designed to enhance stability or modify function?

Designing synthetic variants of TKRP-2 for enhanced stability or modified function can employ several strategic approaches:

• Terminal modifications: N-terminal acetylation or C-terminal amidation to protect against exopeptidase degradation

• Amino acid substitutions:

  • Replace susceptible residues with non-natural amino acids

  • Substitute methionine with norleucine (as demonstrated with TRP2-TINF) to reduce oxidation vulnerability

  • Incorporate D-amino acids at strategic positions to resist proteolytic degradation

• Secondary structure stabilization:

  • Introduce disulfide bridges or lactam bonds to stabilize bioactive conformation

  • Design helix-stabilizing modifications if the peptide adopts a helical structure

• Cyclization: Head-to-tail cyclization to enhance resistance to exopeptidases

• PEGylation: Attachment of polyethylene glycol to increase half-life and reduce immunogenicity

For synthesis of these variants, solid-phase peptide synthesis using the t-Boc strategy with methylbenzhydrylamine resin (MBHAR) has proven effective for related peptides. Purification by HPLC on a C18 column followed by LC-ESI-MS characterization ensures high purity and confirmation of structure. The concentration of synthetic peptides can be determined using the Lambert-Beer law with the molar extinction coefficient at 205 nm absorption .

What approaches can be used to investigate TKRP-2 expression patterns in different tissues and developmental stages?

To comprehensively investigate TKRP-2 expression patterns across tissues and developmental stages, researchers should employ multi-faceted approaches:

• Transcriptomic analysis:

  • RNA sequencing of different tissues and developmental stages

  • Quantitative PCR with TKRP-2 specific primers

  • Comparative analysis across developmental timepoints

• Peptidomic analysis:

  • Liquid chromatography with tandem mass spectrometry (LC-MS/MS) of tissue extracts

  • Comparison of neuropeptidomes across developmental stages

  • Identification of post-translational modifications

• Immunohistochemistry:

  • Development of TKRP-2 specific antibodies

  • Fluorescent labeling of tissues to localize TKRP-2 expression

  • Co-localization studies with receptor (TRPR) expression

• In situ hybridization:

  • Probe design based on TKRP-2 mRNA sequence

  • Visualization of expression in specific neuronal populations

  • Combination with immunostaining for comprehensive mapping

• Reporter gene constructs:

  • CRISPR/Cas9-mediated insertion of reporter genes (GFP, mCherry) under TKRP-2 promoter control

  • Visualization of expression patterns in vivo

Comparative peptidomic studies have successfully identified TKRPs in various insects, including difference analysis between behavioral phenotypes. For example, in honeybees, LC-MS/MS revealed 132 unique neuropeptides derived from 23 neuropeptide families in one subspecies and 116 unique neuropeptides from 22 families in another .

How can CRISPR/Cas9 gene editing be utilized to study TKRP-2 function in vivo?

CRISPR/Cas9 gene editing provides powerful tools for investigating TKRP-2 function in vivo:

• Knockout strategies:

  • Design guide RNAs targeting the TKRP-2 gene

  • Create complete gene knockouts to assess loss-of-function phenotypes

  • Generate conditional knockouts using Cre-lox systems for tissue-specific studies

• Knockin approaches:

  • Insert reporter genes (GFP, luciferase) to track expression patterns

  • Introduce point mutations to study structure-function relationships

  • Create tagged versions of TKRP-2 for interaction studies

• Promoter modifications:

  • Edit regulatory regions to alter expression levels

  • Insert inducible promoters for temporal control of expression

  • Study cis-regulatory elements affecting TKRP-2 expression

• Receptor engineering:

  • Edit the TRPR gene to study receptor-ligand interactions

  • Create constitutively active or dominant-negative receptor variants

  • Investigate signaling pathway components downstream of TRPR

• Behavioral assessment:

  • Analyze behavioral changes in edited organisms

  • Perform task-specific assays similar to those used in honeybee studies

  • Compare response thresholds between wild-type and edited animals

While CRISPR/Cas9 has not been specifically applied to TKRP-2 in Euschistus servus, this methodology has been successfully used in other insect species and would allow researchers to establish causal relationships between TKRP-2 signaling and behavioral or physiological phenotypes similar to those observed in the gain- and loss-of-function experiments performed in honeybees .

How does TKRP-2 from Euschistus servus compare structurally and functionally to TKRPs from other insect species?

TKRP-2 from Euschistus servus is part of a broader family of tachykinin-related peptides found across insect species. Comparative analysis reveals both conservation and divergence:

Structurally, TKRPs across insect species maintain certain conserved regions, particularly in their C-terminal domains, while exhibiting species-specific variations primarily in their N-terminal regions. Functionally, roles range from neuromodulation and behavior regulation to antimicrobial activity, suggesting evolutionary adaptations to diverse ecological niches and physiological requirements .

What is the evolutionary relationship between invertebrate TKRPs and vertebrate tachykinins?

The evolutionary relationship between invertebrate TKRPs and vertebrate tachykinins represents a fascinating example of molecular divergence and functional conservation:

• Structural comparison:

  • Vertebrate tachykinins (e.g., Substance P, Neurokinin A, Neurokinin B) share a consensus C-terminal sequence F-X-G-Y-R-NH₂

  • Invertebrate tachykinins (Inv-TKs) have a different C-terminal motif: F-X-G-L-M-NH₂

  • TKRPs maintain higher homology with vertebrate tachykinins, exhibiting similar C-terminal sequences

• Phylogenetic analysis:

  • TKRPs show up to 30% homology with vertebrate tachykinins

  • Higher similarity (up to 45%) with fish and amphibian tachykinins

  • Suggests ancient evolutionary origins predating the invertebrate-vertebrate split

• Functional conservation:

  • Despite structural differences, TKRPs and vertebrate tachykinins exhibit similar biological effects

  • Both groups function as neuromodulators affecting behavior and physiological processes

  • Similar receptor coupling mechanisms to G-protein pathways

• Receptor evolution:

  • Tachykinin receptors in both vertebrates and invertebrates belong to the G-protein coupled receptor superfamily

  • Signaling pathways show remarkable conservation despite hundreds of millions of years of evolutionary divergence

The first non-mammalian tachykinin discovered was eledoisin from the salivary glands of Eledone moschata, followed by the identification of tachykinins in mosquitoes (Aedes aegypti) and locusts (Locusta migratoria). These discoveries confirmed the presence of peptides related to vertebrate tachykinins in invertebrates, establishing evolutionary links between these neuropeptide systems across diverse animal phyla .

What are the major technical challenges in studying TKRP-2 function and how can they be addressed?

Researchers face several technical challenges when studying TKRP-2 function, along with potential solutions:

• Peptide stability:

  • Challenge: TKRPs are susceptible to enzymatic degradation

  • Solution: Develop modified analogs with enhanced stability; use appropriate protease inhibitors during experiments; optimize storage conditions

• Receptor specificity:

  • Challenge: Potential cross-reactivity with other receptors or peptides

  • Solution: Employ receptor knockout models; use selective antagonists; perform competitive binding assays; develop highly specific antibodies

• Temporal dynamics:

  • Challenge: Capturing rapid signaling events (e.g., ERK phosphorylation peaks at 2 minutes post-stimulation)

  • Solution: Utilize real-time imaging techniques; develop biosensors for live monitoring; implement precise time-course experiments

• In vivo delivery:

  • Challenge: Effective delivery of TKRP-2 to target tissues in living organisms

  • Solution: Develop targeted delivery systems; utilize microinjection techniques; implement optogenetic or chemogenetic approaches for controlled release

• Functional redundancy:

  • Challenge: Multiple TKRPs with potentially overlapping functions

  • Solution: Combined knockout/knockdown of multiple peptides; comprehensive peptidomic analysis; detailed structure-function studies

• Translation to diverse species:

  • Challenge: Variation in TKRP sequences and functions across insects

  • Solution: Comparative evolutionary analyses; systematic testing across multiple species; identification of conserved functional domains

Addressing these challenges requires interdisciplinary approaches combining molecular biology, biochemistry, neuroscience, and behavioral analysis techniques .

What emerging technologies might advance our understanding of TKRP-2 signaling networks?

Several emerging technologies hold promise for advancing our understanding of TKRP-2 signaling networks:

• Single-cell transcriptomics:

  • High-resolution mapping of TKRP-2 and TRPR expression patterns

  • Identification of co-expressed signaling components

  • Reveals cell-type specific signaling networks

• CRISPR-based techniques:

  • Base editing for precise modification of TKRP-2 or TRPR

  • CRISPRi/CRISPRa for temporal control of gene expression

  • Prime editing for introducing specific modifications without double-strand breaks

• Advanced imaging technologies:

  • Super-resolution microscopy for visualizing receptor-ligand interactions

  • Expansion microscopy for detailed neural circuit mapping

  • Light sheet microscopy for whole-organism imaging of signaling activity

• Biosensor development:

  • FRET-based sensors for real-time monitoring of TKRP-2/TRPR interactions

  • Genetically encoded calcium indicators in TRPR-expressing cells

  • Optogenetic tools for spatiotemporal control of signaling

• Computational approaches:

  • Molecular dynamics simulations of TKRP-2/TRPR interactions

  • Machine learning for predicting signaling network responses

  • Systems biology modeling of integrated signaling pathways

• Proteomics advances:

  • Proximity labeling to identify interaction partners

  • Phosphoproteomics to map downstream signaling cascades

  • Cross-linking mass spectrometry for structural characterization

These technologies, individually or in combination, would provide unprecedented insights into how TKRP-2 functions within complex biological systems and neural circuits controlling behavior and physiology .

How might understanding TKRP-2 function contribute to broader research applications in neuroscience and behavioral biology?

Understanding TKRP-2 function has far-reaching implications for multiple research domains:

• Social insect biology:

  • Insights into division of labor mechanisms in eusocial insects

  • Understanding the neurobiological basis of behavioral specialization

  • Models for how neuropeptides regulate social behaviors across species

• Neuromodulation principles:

  • Elucidation of how neuropeptides adjust neural circuit properties

  • Understanding of context-dependent behavioral modulation

  • Insights into evolutionary conservation of neuromodulatory mechanisms

• Comparative neuroscience:

  • Cross-species comparison of tachykinin systems from insects to mammals

  • Understanding evolutionary conservation and divergence of peptidergic systems

  • Identification of fundamental principles in neural circuit regulation

• Behavioral flexibility:

  • Mechanisms underlying adaptive behavioral responses to environmental changes

  • Understanding how neuropeptides regulate response thresholds

  • Insights into the neurochemical basis of behavioral plasticity

• Translational applications:

  • Models for understanding tachykinin function in human neurological conditions

  • Development of peptide-based therapeutics targeting tachykinin systems

  • Novel approaches for agricultural pest management based on species-specific TKRPs

The role of TRP2 in modulating task-specific behaviors in honeybees provides a model system for understanding how neuropeptide signaling contributes to behavioral specialization more broadly, with potential applications ranging from understanding social behavior evolution to developing novel therapeutic approaches for conditions involving dysregulated tachykinin signaling in humans .